Songjiang Ma 13D and 13G filings for Gyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 06:01 am Sale | 2026-05-04 | 13D | GYRE THERAPEUTICS INC GYRE | Songjiang Ma | 7,342,131 6.330% | -114,716 (-1.54%) | Filing |
| 2024-09-06 08:31 am Purchase | 2024-09-06 | 13D | GYRE THERAPEUTICS INC GYRE | Songjiang Ma | 7,456,847 7.620% | 7,456,847 (New Position) | Filing |